BIT
EBS icon

BlackRock Institutional Trust’s Emergent Biosolutions EBS Stock Holding History

BlackRock Institutional Trust’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$28.3M Buy
861,799
+65,975
+8% +$1.98M ﹤0.01% 1710
2016
Q3 		$25.1M Sell
795,824
-71,027
-8% -$2.06M ﹤0.01% 1717
2016
Q2 		$24.4M Buy
866,851
+20,226
+2% +$793K ﹤0.01% 1717
2016
Q1 		$30.8M Sell
846,625
-11,404
-1% -$403K 0.01% 1530
2015
Q4 		$34.3M Buy
858,029
+35,549
+4% +$1.24M 0.01% 1492
2015
Q3 		$23.4M Sell
822,480
-87,542
-10% -$2.88M ﹤0.01% 1728
2015
Q2 		$30M Sell
910,022
-39,797
-4% -$1.23M ﹤0.01% 1631
2015
Q1 		$27.3M Buy
949,819
+716
+0.1% +$20.5K ﹤0.01% 1732
2014
Q4 		$25.8M Sell
949,103
-8,395
-0.9% -$200K ﹤0.01% 1740
2014
Q3 		$20.4M Sell
957,498
-29,173
-3% -$668K ﹤0.01% 1851
2014
Q2 		$22.2M Buy
986,671
+5,000
+0.5% +$116K ﹤0.01% 1891
2014
Q1 		$24.8M Buy
981,671
+15,956
+2% +$403K ﹤0.01% 1817
2013
Q4 		$22.2M Buy
965,715
+12,391
+1% +$258K ﹤0.01% 1861
2013
Q3 		$18.2M Buy
953,324
+27,634
+3% +$493K ﹤0.01% 1935
2013
Q2 		$13.3M Buy
+925,690
New +$13.4M ﹤0.01% 2119

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BlackRock Institutional Trust's EBS Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Emergent Biosolutions (EBS) stake by 8.3% in Q4 2016, buying an estimated $1.98M and bringing the position to 861,799 shares worth $28.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1710.

BlackRock Institutional Trust first reported a position in EBS in Q2 2013 and has held it in 15 quarters since. The position peaked at $34.3M in Q4 2015. 208 funds tracked by Wall St. Rank hold EBS as of Q4 2016.

  • BlackRock Institutional Trust held 861,799 shares of Emergent Biosolutions worth $28.3M as of Q4 2016.
  • BlackRock Institutional Trust bought 65,975 Emergent Biosolutions shares in Q4 2016, an estimated $1.98M.
  • Emergent Biosolutions made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1710 holding.
  • BlackRock Institutional Trust first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Emergent Biosolutions position peaked at $34.3M in Q4 2015.
  • 208 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.